👍👏 work by Sanghee Hong - do stop by her poster #3600 to learn about psychosocial factors and #BMT outcomes #ash18

👍👏 presentation by #CCFIMRPalum Sanghee Hong at #TCTM19 on community risk factors and allo #BMT outcomes using CIBMTR data

👍 work by #CleClinicBMT fellow ⁦Sanghee Hong⁩ et al: Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipients ⁦Bone Marrow Transplantation⁩ nature.com/articles/s4140…

Sanghee Hong discussing her upcoming presentations here at #ASH19 #CleClinicCancer Cleveland Clinic MD

#TCTM20 👍👏 work by #CleClinicBMT fellow Sanghee Hong #CleClinicCancer

😎 thing about in person #ASH21 meeting is the ability to meet and interact with 🌟 trainees (tho this Gen X’er had to take the 🤳 🤷‍♂️)

#ASHKudos to Julia Joo, MPH Sanghee Hong for an outstanding job at #ASH21 - 🌟🌟🌟 Cleveland Clinic MD mentees who make me look better 🙏

#ASH21 anti-leukemic effect by inducing p21 by MDM2/XPO1 inhibition for van/HMA resistant AML by Yuki Nishida from MD Anderson Valeria Visconte

#ASH21 ✅ out our poster on resource utilization of Omidubicel vs cord blood #BMT today at 6 pm ativsoftware.com/appinfo.php?pa… #ASH21

In light of ⁦NEJM⁩ study on #VitD, about time we do a solid RCT in #BMT to address this issue; surfacing review by ⁦Sanghee Hong⁩ et al ⁦Bone Marrow Transplantation⁩ To D or not to D: vitamin D in hematopoietic cell transplantation nature.com/articles/s4140…

The Phase 3 study of Gilt + Aza vs Aza in newly-dx FLT3m AML in pts that could not receive intensive chemo is out in Blood Journal ! #leusm -mOS 9.82 mon Gilt + Aza and 8.87 mon Aza (p=.75) -similar CR rates: Gilt + aza 16.2%, Aza 14.3% ashpublications.org/blood/article/…

Today the The White House announced that all federally funded research will be made openly available. Importantly, it eliminates the 12-month embargo. This is the result of decades of work by SPARC, Peter Suber (@[email protected]), Michael Eisen, and so many more. #OpenAccess whitehouse.gov/ostp/news-upda…

Brilliant overview of the hla loss mechanism and frequency across donors, cord blood cells have unique properties, by Luca Vago at The EBMT #ITC22, The EBMT Trainee Committee

#Tandem23 Twitter is dated. The future belongs to TikTok. ⁦@BeTheMatch⁩ needs to immediately engage with Dr Fingrut.

Join the Education Committee this Thursday, March 23, for the next #ASTCTChat. Starting at 9 AM CT, questions will be posted hourly on Twitter. Join in the conversation using #ASTCTChat: ow.ly/8Pce50Nlzxa

Yes, clonal evolution in MF does matter! 🙏 To Nico Gagelmann for leading this amazing collaboration !

We are happy to share Prof. Fleischhauer's commentary on this very relevant study by our CIBMTR colleagues, now available in Transplantation and Cellular Therapy Journal. Incorporating #HLA-DP permissive mismatches results in optimal likelihoods of finding well-matched unrelated donors for our #HCT patients!

A study of 567 people who were alive and cancer-free 1 year after #BMT found that most were highly confident about knowledge in their survivorship. Learn more about this CIBMTR study: cibmtr.org/Files/Patient-…

Great work Sanghee Hong #ASH16 Cleveland Clinic IM 👍👍👍

#CCFBMT will be in full tweeter force at #BMTTandem17 Rob Dean, MD Betty Ky Hamilton @DeepJag00 @frar915 Sagar Patel, MD Sanghee Hong Rabi Hanna Aron Flagg, MD